Esther Khan-Masih
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis-Requiring Severe Renal Impairment.
Journal: European journal of haematology
Published: October 09, 2025
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.
Journal: Blood cancer discovery
Published: September 30, 2025
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 19, 2025
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities.
Journal: EJHaem
Published: November 14, 2024
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
Journal: Blood cancer journal
Published: August 27, 2023
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.
Journal: Blood cancer journal
Published: June 18, 2023
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
Journal: European journal of haematology
Published: May 12, 2023
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.
Journal: Blood cancer journal
Published: April 19, 2023
The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 03, 2023
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
Journal: Blood cancer journal
Published: February 23, 2023
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 01, 2022
Last Updated: 09/26/2026